Home › Products › Oncology › Nubeqa 300mg Tablet
Nubeqa 300mg Tablet
Salt Composition: DAROLUTAMIDE
- Manufacturer: BAYER PHARMACEUTICALS PVT LTD
- Pack Size: 112 TABLET(s) IN A BOX
- Dosage Form: TABLET
- Strength: 300MG
- Prescription Required
- Storage: Keep Darolutamide out of sight and reach of children. This medication is to be stored at or below 30 °C. If you missed your regular dose, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose. Inform your physician about the missed dose. Do not take 2 doses at the same time.
₹254167.00₹322546.91
Inclusive of all taxes
Product Introduction
Nubeqa 300mg tablet contains the active ingredient darolutamide, an androgen receptor inhibitor indicated for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved for hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications. Darolutamide works by controlling the growth of prostate cancer cells and can improve treatment outcomes when combined with other therapies. Patients with prostate cancer should follow the prescribed dosage as advised by their doctor. As with any cancer treatment, regular monitoring is essential to assess response and manage any adverse effects that may occur. Pricing for Nubeqa 300mg varies depending on the pharmacy and region in India. The medication is available through certified online pharmacy platforms. Comparative data exists between darolutamide and enzalutamide as treatment options for eligible patients. Clinical trial data supports the effectiveness and safety profile of darolutamide in the indicated patient populations. Information regarding patient assistance programmes may be available to help manage treatment costs.
Uses
Non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment) Hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.
How it works
Nubeqa 300mg works by inhibiting the activity of androgens (testosterone) which are male sex hormones. Inhibition of these hormones stops the growth, division and multiplication of cancer cells.
How to Use
Nubeqa tab 300 mg is to be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with food and water. The frequency of administration will be decided by your doctor based on the severity.
Side Effects
Nubeqa 300 mg side effects are unwanted symptoms caused by medicines. Even though all medicines cause nubeqa side effects, not everyone gets them. Common: Fatigue Rash Muscle pain Bone pain Pain in the arms and legs Broken bones Serious: Chest pain Pain in arms, jaw, neck and back Lightheadedness or dizzy Shortness of breath Swelling of ankles and legs Seizures
References
- Bayer (Pty) Ltd, Patient information leaflet, [Revised on 15th March 2022], [Accessed on 8th August 2022], https://www.bayer.com/sites/default/files/NUBEQA_EN_PIL.pdf#page=2
- Orion Corporation, Orion Pharma, Electronics Medicine Compendium (emc), [Revised on January 2021], [Accessed on 8th August 2022], https://www.medicines.org.uk/emc/files/pil.11324.pdf
- Bayer HealthCare Pharmaceuticals Inc, U.S. Food and Drug Administration, [Revised on July 2019], [Accessed on 8th August 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: hormones and related agents, 12th edition, 2011, 1707 - 1709.
Safety Advice
Pregnancy: unsafe Nubeqa 300mg Tablet is only for use in men. This drug is not recommended for use in women, especially if they are pregnant, because it may cause harm to the unborn baby and result in loss of pregnancy. It is better to discuss with a doctor to use of an effective contraceptive method during the treatment and for 1 week after the last dose if your male partner is consuming this medicine. It is recommended to consult your physician if you are pregnant already or suspect pregnancy.
Lungs: Consult your doctor It is unknown whether Nubeqa 300mg Tablet can be administered to patients with lung diseases. Inform your doctor if you have any lung problems before starting the treatment.
Breastfeeding: unsafe Nubeqa 300mg tablet is not indicated in females. It is unknown whether this medicine is excreted in human milk. It is difficult to rule out benefits over risk for the nursing infant, hence it should not be used during breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.